GAIL NAUGHTON
Profile
First Name
: GAIL
Middle Name
:
Last Name
: NAUGHTON
Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER, DIRECTOR
EXECUTIVE OFFICER
GARY C. BURGESS, CHARLES J. CASHION, JENNIFER GIOTTONINI CAYER, STEPHEN CHANG, PH.D., DAVID H. CREAN, DAVID CREAN, PH.D., MOYA DANIELS, ROCHELLE FUHRMANN, WILLIAM GERBER, WILLIAM GERBER, M.D., DAVID F. HALE, JONATHAN JACKSON, DANIEL L. KISNER, DANIEL KISNER, M.D., PAUL KLINGENSTEIN, PAUL H. KLINGENSTEIN, SUSAN A. KNUDSON, LOUIS LACASSE, MARTIN LATTERICH, SHAHZAD MALIK, SHAHZAD MALIK, M.D., STEVEN J. MENTO, STEVEN MENTO, PH.D., STEVEN J. MENTO, PH.D., GAIL K. NAUGHTON, RICHARD W. PASCOE, MARC PERET, MARC PERRET, JOYCE REYES, BRIAN SATZ, BRIAN SATZ, ESQ., JAMES SCOPA, ALFRED P. SPADA, ALFRED P. SPADA, PH.D., HAROLD VAN WART, HAROLD VAN WART, M.D., SUSAN WINDHAM-BANNISTER, HAYDEN YIZHUO ZHANG
DIRECTOR
DIRECTOR
BRIAN BERNICK, BRIAN BERNICK, M.D., PAUL BISARO, PAUL M. BISARO, EDWARD BORKOWSKI, J. MARTIN CARROLL, DANIEL A. CARTWRIGHT, COOPER C. COLLINS, JAMES C. D-ARECCA, MICHAEL DONEGAN, MICHAEL C. DONEGAN, ROBERT G. FINIZIO, MARK GLICKMAN, SAMUEL A. GRECO, MITCHELL L. KRASSAN, ROBERT V. LAPENTA, JR., KAREN LING, KAREN L. LING, JOHN C.K. MILLIGAN IV, JOHN C.K. MILLIGAN, IV, JULES A. MUSING, GAIL K. NAUGHTON, HUGH O-DOWD, JUSTIN ROBERTS, ANGUS C. RUSSELL, NICHOLAS SEGAL, TOMMY G. THOMPSON, MARLAN WALKER, MARLAN D. WALKER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-06-29
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-10-28
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-09-30
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-07-29
